Announcements Trials
Browse Landscape

Phase

Phase NA 11Phase 2 1

Status

Recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Other solid neoplasm 2Thoracic 1Other hematologic neoplasm 1Lymphoid 1Head & Neck 1

Conditions

Depressive Disorder 1Carcinoma, Non-Small-Cell Lung 1

Interventions

Carboplatin 547Pemetrexed 402Cisplatin 400Paclitaxel 272Docetaxel 255Gemcitabine 218pembrolizumab 190Bevacizumab 190Erlotinib Hydrochloride 184Radiotherapy 179Etoposide 147durvalumab 140Nivolumab 134Drug Therapy 127osimertinib 106atezolizumab 92Gefitinib 74Radiosurgery 71anlotinib 69Vinorelbine 68tislelizumab 52Irinotecan 51Ipilimumab 50130-nm albumin-bound paclitaxel 49Taxes 48Surgical Procedures, Operative 46Cetuximab 46sintilimab 45Albumin-Bound Paclitaxel 45apatinib 44

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase 2 × Interviews as Topic × Thoracic × Clear all
NCT07216404 2026-05-14

Psilocybin-Assisted Therapy for the Treatment of Major Depressive Disorder in Patients With Non-Small Cell Lung Cancer

Ohio State University Comprehensive Cancer Center

Phase 2 Recruiting
10 enrolled
Thoracic

Carcinoma, Non-Small-Cell Lung, Depressive Disorder

Data powered by HemOnc (CC BY 4.0) Colophon âš¡